IP Library Granted Patent US 7,514,541
Granted Patent B2
US 7,514,541 · App. 11/185,575 · Granted Apr 7, 2009

Process for the production of multiple cross-linked hyaluronic acid derivatives

Assignee: Mentor Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,514,541
App. No.
11/185,575
Granted
Apr 7, 2009
Kind
B2
Abstract

The present invention relates to a process for the production of cross-linked hyaluronic acid (HA) derivatives, in particular multiple, e.g. double cross-linked hyaluronic acid derivatives. The invention also provides novel cross-linked HA derivatives, products containing them and their uses in medical and pharmaceutical and cosmetic applications.

Claims (16)

1. A process for the preparation of multiple cross-linked hyaluronic acid (HA), which process comprises covalently cross-linking HA via two or more different functional groups, wherein said cross-linking is effected by contacting HA with two or more chemical cross-linking agents so as to form two or more different types of functional bonds between HA molecules under one of an acidic or an alkaline condition without altering such condition, and wherein said two or more different types of functional bonds are selected from the group consisting of ether, ester, sulfone, amine, imino, and amide bonds.

2. A process according to claim 1 wherein the functional groups are selected from hydroxyl, carboxyl and amino.

3. A process according to claim 1 wherein the cross-linking agent is selected from the group consisting of formaldehyde, gluteraldehyde, divinyl sulfone, a polyanhydride, a polyaldehyde, a polyhydric alcohol, epichlorohydrin, ethylene glycol diglycidylether, butanediol diglycidylether, polyglycerol polyglycidylether, polyethylene glycol diglycidylether, polypropylene glycol diglycidylether, and a bis-or poly-epoxy cross-linker.

4. A process according to claim 1 wherein an ether bond is formed using a cross-linking agent selected from the group consisting of bis epoxides and poly epoxides under alkaline conditions.

5. A process according to claim 1 wherein an ester bond is formed using a cross-linking agent selected from the group consisting of bis epoxides and poly epoxides under acidic conditions.

6. A process according to claim 4 wherein the cross-linking agent is selected from the group consisting of 1,2,3,4-diepoxybutane and 1,2,7,8-diepoxyoctane.

7. A process according to claim 1 wherein an ether bond is formed using a gluteraldehyde cross-linking agent under acidic conditions.

8. A process according to claim 1 wherein the cross-linking of each type of functional group is effected sequentially.

9. A process according to claim 8 wherein HA is first cross-linked via the hydroxyl groups by formation of ether bonds and subsequently cross-linked via the carboxyl groups by formation of ester bonds.

10. A process according to claim 1 wherein the cross-linking of each type of functional group is effected simultaneously.

11. A process according to claim 1 wherein said multiple cross-linked HA is cross-linked with two or more chemical cross-linking agents so as to form two different types of functional bonds.

12. A process according to claim 11 which comprises:

(a) cross-linking HA via a first functional group and

(b) subsequently cross-linking the product of (a) via a second functional group, wherein said first and second functional groups represent different chemical entities.

13. The process of claim 1 , wherein said two or more different types of functional bonds are selected from the group consisting of ester and amine bonds.

14. A process for the preparation of multiple cross-linked hyaluronic acid (HA), which process comprises covalently cross-linking HA via two or more different functional groups, wherein said cross-linking is affected by contacting HA with two or more chemical cross-linking agents so as to form two or more different types of functional bonds between HA molecules under one of an acidic or an alkaline condition without altering such condition.

Assignments (1)
CHANGE OF NAME Recorded Mar 4, 2010
From: MENTOR CORPORATION
To: MENTOR WORLDWIDE LLC
Reel/Frame 024023/0607 →
Priority Claims (1)
GB 9902412.7 · Feb 3, 1999 · national
Continuity (3)
Continuation 0992028600 · Aug 2, 2001
Continuation PCTGB000032100 · Feb 3, 2000
Related Publication 20050250939A1 · Nov 10, 2005